Walleye Trading LLC Dynavax Technologies Corp Transaction History

Walleye Trading LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$11.7 - $14.98 $136,269 - $174,472	11,647 New	11,647 $144,000
Q4 2022 Feb 14, 2023	BUY	$10.27 - $13.29 $35,903 - $46,461	3,496 Added 41.1%	12,002 $127,000
Q3 2022 Nov 14, 2022	SELL	$9.93 - $17.44 $105,665 - $185,579	-10,641 Reduced 55.58%	8,506 $89,000
Q2 2022 Aug 08, 2022	BUY	$7.45 - $12.83 $30,418 - $52,384	4,083 Added 27.1%	19,147 $241,000
Q1 2021 May 17, 2021	SELL	$4.57 - $11.18 $8,596 - $21,029	-1,881 Reduced 11.1%	15,064 $148,000
Q2 2020 Aug 14, 2020	BUY	$2.94 - $9.1 $49,818 - $154,199	16,945 New	16,945 $150,000
Q3 2019 Nov 14, 2019	SELL	$2.69 - $4.85 $186,610 - $336,454	-69,372 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$3.65 - $7.89 $253,207 - $547,345	69,372 New	69,372 $277,000

273

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.6B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.